Australian Biotech Cautious Of Proposed Expedited Review Process for Novel Devices
This article was originally published in SRA
Executive Summary
Australia's biotech industry association, AusBiotech, has cautioned the government against investing resources in creating a new accelerated pathway for the approval of novel medical devices as this would amount to diverting resources away from making "more desirable" changes to the existing approval pathways1,2.